|
The Technology
Augurex Technology Pipeline
With the short development timelines for biomarker development, Augurex is building
a multi-product company with technologies that fill significant unmet medical needs
in the protein biomarker area and has additional technologies under evaluation.
With AGX-020 being a biomarker that provides useful information for the management of
arthritis, Augurex is also developing the therapeutic applications of targeting the
protein. With the successful outcomes of these research and development programs, AGX-020
can potentially represent the first personalized medicine approach in arthritis through
the use of a novel diagnostic test to select the appropriate patients for this targeted
therapy.
Scientists or universities who are interested in advancing their technologies in partnership
with Augurex Life Sciences Corp. are welcome to contact us.
|
